ArticleFrontiers in pharmacology2026

Stage IIIB ROS1-Positive NSCLC management: crizotinib + surgery + TCM achieves exceptionally prolonged PFS (a case report).

Yu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.